ORG-47241

From WikiMD's Wellness Encyclopedia

ORG-47241

ORG-47241 is a synthetic compound that has been studied for its potential therapeutic effects in various medical conditions. It is primarily known for its role as a selective agonist of the serotonin 5-HT2A receptor, which is implicated in a range of neurological and psychiatric disorders.

Chemical Structure and Properties[edit | edit source]

ORG-47241 is a small molecule with a complex chemical structure that allows it to interact specifically with the 5-HT2A receptor. The compound's molecular formula is C20H25N3O2, and it has a molecular weight of 339.44 g/mol. The structure includes a core indole moiety, which is a common feature in many serotonin receptor ligands.

Pharmacology[edit | edit source]

The primary mechanism of action of ORG-47241 is its selective agonism at the 5-HT2A receptor. This receptor is a subtype of the serotonin receptor family, which is involved in the modulation of neurotransmission in the central nervous system. Activation of the 5-HT2A receptor by ORG-47241 can lead to various downstream effects, including alterations in mood, perception, and cognition.

Receptor Binding[edit | edit source]

ORG-47241 exhibits high affinity for the 5-HT2A receptor, with a dissociation constant (K_d) in the nanomolar range. This high affinity is indicative of its potent agonistic activity, which has been demonstrated in both in vitro and in vivo studies.

Therapeutic Potential[edit | edit source]

Research into ORG-47241 has explored its potential use in treating conditions such as depression, anxiety, and schizophrenia. The compound's ability to modulate serotonin signaling makes it a candidate for addressing the dysregulation of this neurotransmitter system observed in these disorders.

Clinical Studies[edit | edit source]

Several preclinical studies have been conducted to evaluate the efficacy and safety of ORG-47241. These studies have shown promising results, with the compound demonstrating significant effects in animal models of depression and anxiety. However, clinical trials in humans are necessary to fully establish its therapeutic potential and safety profile.

Side Effects and Safety[edit | edit source]

As with many compounds that affect the central nervous system, ORG-47241 may have side effects related to its pharmacological activity. Potential side effects include alterations in mood, perception, and cognition, which are consistent with its action on the 5-HT2A receptor. Long-term safety studies are required to better understand the risk profile of this compound.

Also see[edit | edit source]

Template:Receptor pharmacology Template:Psychopharmacology

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD